#6386 on the rich list of 14,644 insiders
Douglas S. Ingram
Chief Executive Officer at Sarepta Therapeutics; Director at Arrowhead Pharmaceuticals. Based in Pasadena, California.
$15.2M
in disclosed stock, −$310K (−2.00%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 6386th of 14,644
- Companies held
- 2
- Largest holding
- SRPT, 86.7% of total
- Latest SEC filing
- Dec 16, 2025
What the $15.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Sarepta Therapeutics SRPT Common Stock | Directly | 929,391 | $14.17 | $13.2M | 86.7% | Form 4, Dec 7, 2025 |
| Arrowhead Pharmaceuticals ARWR Common Stock | Directly | 46,215 | $43.65 | $2.0M | 13.3% | Form 4, Dec 16, 2025 |
Share counts are the amounts Douglas S. Ingram reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6383 | Timothy G. Wallace Chairman, CEO and President, Community Healthcare Trust. Franklin, TN | $15.2M |
| 6384 | Jie Xiao Chief Executive Officer, YSX Tech. Co. | $15.2M |
| 6385 | Lih Shyng (Rick) Tsai Director, Lam Research. Fremont, CA | $15.2M |
| 6386 | Douglas S. Ingram Chief Executive Officer, Sarepta Therapeutics. Pasadena, CA | $15.2M |
| 6387 | Bruce M. Larson Chief Human Resources Officer, The Carlyle Group. Washington, DC | $15.2M |
| 6388 | Tracey Thomas Travis Director, Meta Platforms. Chicago, IL | $15.2M |
| 6389 | Ivonne M. Cabrera SVP, General Counsel & Secr., Dover. Downers Grove, IL | $15.2M |
Other Sarepta Therapeutics insiders
All SRPT insiders- Richard Barry$45.8MDirector. #2666 overall
- Michael Severino$10.7MChief Executive Officer. #2349 overall
- Michael Chambers$7.1MDirector. #11242 overall
Questions
How much stock does Douglas S. Ingram own?
Douglas S. Ingram holds $15,186,755 in listed stock based on SEC filings and current prices, mostly Sarepta Therapeutics (SRPT). That ranks 6386th on the Stock Rich List.
Is this Douglas S. Ingram's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.